Increased health‐related quality of life impairments of male and female survivors of childhood cancer: DCCSS LATER 2 psycho‐oncology study
Marloes van Gorp(Princess Máxima Center), Helena J. H. van der Pal, Heleen Maurice‐Stam(Princess Máxima Center), Eline van Dulmen‐den Broeder(Erasmus MC), Marry M. van den Heuvel‐Eibrink(Princess Máxima Center), Loes M. E. van Erp(Princess Máxima Center), Martha A. Grootenhuis(Princess Máxima Center), Marloes Louwerens(Leiden University Medical Center), Anne Maas(University of Lucerne), Leontien C.M. Kremer(Emma Kinderziekenhuis), Cécile M. Ronckers(Johannes Gutenberg University Mainz), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wim J. E. Tissing(University Medical Center Groningen), Margriet van der Heiden‐van der Loo(Princess Máxima Center), Gea A. Huizinga(University Medical Center Groningen), Jacqueline J. Loonen(Radboud University Nijmegen), Andrica C. H. de Vries(Princess Máxima Center)
Cited by 26
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553